Results 121 to 130 of about 63,132 (220)

Analysis of Modified Vaccinia Ankara Tropism and Growth Conditions [PDF]

, 2018
Vaccinia is a large enveloped virus belonging to the poxvirus family. It has linear, double stranded DNA, averaging about 190 kbp in length. Although vaccinia's origin is unknown, it is closely related to cowpox, smallpox and horsepox.
Boumediene, Synda, Nash, Paul
core  

Vaccinia

International Journal of Clinical Practice, 1954
openaire   +2 more sources

VACCINIA AND VARIOLA [PDF]

American Journal of Public Health, 1925
openaire   +2 more sources

Thyroid Hormones Deficiency Worsens Outcomes in Vaccinia Virus Infection

[Description of methods used for collection/generation of data] Excell.[Methods for processing the data] graphpad prism 8.La inhalación intranasal del virus vaccinia en ratones provoca una infección pulmonar aguda seguida de daño en los órganos ...
Guerrero-Espinosa, Erika, Nistal, Manuel, Aranda, Ana, Lauzurica, Pilar, Notario, Laura, Alemany, Susana   +5 more
core   +1 more source

The bisbenzimide compound ridinilazole has antiviral activity against vaccinia and mpox viruses. [PDF]

J Gen Virol
El-Jesr M, Eke L, Strang BL, Maluquer de Motes C, Sumner RP.   +4 more
europepmc   +1 more source

Intravenously deliverable oncolytic virus VET3-TGI favorably alters the tumor microenvironment. [PDF]

J Immunother Cancer
Zhang M, Barrett K, Carter C, Sampath P, Acosta-Barreto G, Audino S, Moongdee J, Bouchard R, Dunstane D, Matteo N, Biery K, Duyvesteyn E, Cantos M, Brothers KM, Byrd D, Dietrich T, Muthuswamy R, Thorne SH.   +17 more
europepmc   +1 more source

Generalized Vaccinia treated by Convalescent Vaccinia Serum [PDF]

BMJ, 1944
G, Chesney, A A, Jubb
openaire   +2 more sources

Treatment sequence of stem cell delivered heterologous oncolytic virus impact on tumor microenvironment in immunocompetent ovarian cancer model. [PDF]

Front Immunol
Abd El-Fattah EE, Flores L, Lara J, Ngai G, Mooney R, Aboody K.   +5 more
europepmc   +1 more source

PregInPoxVac maternal protocol: a phase 3 trial evaluating maternal immunogenicity and safety of the MVA-BN vaccine in the Democratic Republic of the Congo. [PDF]

BMJ Open
Morales Ruiz P, Milolo Tshilumba S, Maertens K, Maketa V, Kimbulu P, Mitashi F, Abu Azoum M, Kasereka G, Bisumba A, Salloum M, Bikoli-Bolombo F, Le Prevost M, Lemey G, Makenga G, Van Damme P, Van Geertruyden JP, Muhindo-Mavoko H, Mitashi P, Zola Matuvanga T, Larivière Y.   +19 more
europepmc   +1 more source

Dynamics of Orthopoxvirus Stability Under Simulated Luminal Conditions of the Gastrointestinal Tract for Assessing the Feasibility of Oral Immunization. [PDF]

Vaccines (Basel)
Kutumbetov L, Azanbekova M, Myrzakhmetova B, Tuyskanova M, Valieva A, Sarsenkulova N, Zhapparova G, Muzarap D, Mambetaliyev M, Kilibayev S, Zhugunissov K.   +10 more
europepmc   +1 more source